Influence of the metering chamber volume and actuator design on the aerodynamic particle size of a metered dose inhaler

Drug Development and Industrial Pharmacy

Volumn 29, Issue 8, 2003, Pages 865-876

  Berry, Julianne ^a   Heimbecher, Susan ^a   Hart, John L ^a   Sequeira, Joel ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Actuator; Cascade impaction; Laser diffraction; Metered dose inhaler; Particle size; Valve

Indexed keywords

APAFLURANE; PROPELLANT;

AEROSOL; ARTICLE; DRUG DELIVERY SYSTEM; DYNAMICS; MEASUREMENT; METERED DOSE INHALER; PARTICLE SIZE; SENSITIVITY AND SPECIFICITY;

ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; DRUG DELIVERY SYSTEMS; EQUIPMENT DESIGN; HYDROCARBONS, FLUORINATED; METERED DOSE INHALERS; PARTICLE SIZE; SUSPENSIONS; TECHNOLOGY, PHARMACEUTICAL;

EID: 0141680642     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.1081/DDC-120024182     Document Type: Article

References (32)

1. Dolovich, M. Characterization of medical aerosols: physical and clinical requirements for new inhalers. Aerosol Science and Technology 1995, 22, 392-399.
2. Elvecrog, J. Metered dose inhalers in a CFC-Free future. Pharmaceutical Technology Europe 1997, 9 (1), 52-55.
3. Keller, M. Innovations and perpectives of metered dose inhalers in pulmonary drug delivery. International Journal of Pharmaceutics 1999, 186, 81-90.
4. Dunbar, C.A.; Watkins, A.P.; Miller, J.F. Characterization of the pMDI Spray using Numerical Methods. Proceedings of ICLASS 1997, August 18-22, 876-883.
5. Dunbar, C.A. Atomization mechanisms of the pressurized metered dose inhaler. Particulate Science and Technology 1998, 15 (3-4), 253-271.
6. Polli, G.P.; Grim, W.M.; Bacher, F.A.; Yunker, M.H. Influence of formulation on aerosol particle size. Journal of Pharmaceutical Sciences 1969, 58 (4), 484-486.
7. Moren, F. Drug deposition of pressurized inhalation aerosols I. Influence of actuator tube design. International Journal of Pharmaceutics 1978, 1, 205-212.
8. Kim, C.S.; Trujillo, D.; Sackner, M.A. Size aspects of metered dose inhalers. American Review of Respiratory Disease 1985, 132 (1), 137-142.
9. Clark, A.R. The physics of aerosol formation by MDIs-limitations of the current approach. Journal of Biopharmaceutical Sciences 1992, 3 (1/2), 69-76.
10. Brambilla, G.; Ganderton, D.; Garzia, R.; Lewis, D.; Meakin, B.; Ventura, P. Modulation of aerosol clouds produced by pressurized inhalation aerosols. International Journal of Pharmaceutics 1999, 186 (1), 53-61.
11. Dolovich, M.B.; Ruffin, R.E.; Roberts, R.; Newhouse, M.T. Optimal delivery of aerosols from metered dose inhalers. Chest 80 (suppl) 1981, 911-915.
12. Meyer, K.C.; Auerbach, W.R. Drug delivery to the lung. In Polymeric Site-Specific Pharmacotherapy; Domb, A.J., Eds.; John Wiley and Sons: New York, 1994; 347-367.
13. Pritchard, J.N. The influence of lung deposition on clinical response. Journal of Medicine 2001, 14 (1), S19-S26.
14. Leach, C.L.; Davidson, P.J.; Boudreau, R.J. Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone. European Respiratory Journal 1998, 12, 1346-1353.
15. Matthys, H. Chlorofluorocarbon-free aerosol therapy in patients with pulmonary airflow obstruction. Respiration 1996, 63 (3), 321-324.
16. Milosovich, S. Particle size determination via cascade impaction. Pharmaceutical Technology 1992, 16, 82-86.
17. Johnsen, M.A. Properties of aerosol particles. Spray Technology and Marketing 1992, 2 (8), 46-55.
18. United States Pharmacopeia 25, General Chapter 601 (2001), 1969-1980.
19. Ranucci, J. Dynamic plume-particle size analysis using laser diffraction. Pharmaceutical Technology 1992, 16, 108-114.
20. Witt, W.; Rothele, S. Laser diffraction-unlimited? Part. Syst. Charact. 1996, 13 280-286.
21. Le Brun, P.P.H.; de Boer, A.H.; Gjaltema, D.; Hagedoorn, P.; Heijerman, H.G.M.; Frijlink, H.W. Inhalation of tobramycin in cystic fibrosis. International Journal of Pharmaceutics 1999, 189 (2), 205-214.
22. Steckel, H.; Muller, B.W. Metered-dose inhaler formulation of fluticasone-17-propionate micronized with supercritical carbon dioxide using the alternative propellant HFA-227. International Journal of Pharmaceutics 1998, 173, 25-33.
23. Warren, S.J.; Farr, S.J. Formulation of solution metered dose inhalers and comparison with aerosols emitted from conventional suspension systems. International Journal of Pharmaceutics 1995, 124, 195-203.
24. Evans, R.M.; Farr, S.J.; Armstrong, N.A.; Chatham, S.M. Formulation and in vitro evaluation of pressurized inhalation aerosols containing isotropic systems of lecithin and water. Pharmaceutical Research 1991, 8 (5), 629-635.
25. Newman, S.; Pitcairn, G.; Steed, K.; Harrison, A.; Nagel, J. Deposition of fenoterol from pressurized metered dose inhalers containing hydrofluoroalkanes. Journal of Allergy and Clinical Immunology 1999, 104 (6), S253-257.
26. Ranucci, J.A.; Cooper, D.; Sethachutkul, K. Effect of actuator design on metered dose inhaler plume particle size. Pharmaceutical Technology 1992, 16, 84-92.
27. Vervaet, C.; Byron, P.R. Drug-surfactant-propellant interactions in HFA-formulations. International Journal of Pharmaceutics 1999, 186, 13-30.
28. Gabrio, B.J.; Stein, S.W.; Velasquez, D.J. A new method to evaluate plume characteristics of hydrofluoroalkane and chlorofluorocarbon metered dose inhalers. International Journal of Pharmaceutics 1999, 186 (1), 3-12.
29. Moren, F. Drug deposition of pressurized inhalation aerosols II. Influence of vapour pressure and metered volume. International Journal of Pharmaceutics 1978, 1, 213-218.
30. Newman, S.P.; Moren, F.; Pavia, D.; Corrado, O.; Clarke, S.W. The effects of changes in metered volume and propellant vapour pressure on the deposition of pressurized inhalation aerosols. International Journal of Pharmaceutics 1982, 11, 337-344.
31. Williams, R.O., III; Liu, J.; Koleng, J.J. Influence of metering chamber volume and water level on the emitted dose of a suspension-based pMDI containing Propellant 134a. Pharmaceutical Research 1997, 14 (4), 438-443.
32. Tiwari, D.; Goldman, D.; Malick, W.A.; Madan, P.L. Formulation and evaluation of albuterol metered dose inhalers containing tetrafluoroethane (P134a), a Non-CFC Propellant. Pharmaceutical Development and Technology 1998, 3 (2), 163-174.